» Articles » PMID: 18671331

Severe Nontuberculous Mycobacterial Infection in 2 Patients Receiving Rituximab for Refractory Myositis

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2008 Aug 2
PMID 18671331
Citations 17
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Systemic Lupus Erythematosus Patient with Cutaneous Infection under Belimumab Treatment: A Case Report.

Kim J, Hasegawa T, Tada K, Uehara Y, Fukui Y, Nakamura A Ann Dermatol. 2023; 35(Suppl 1):S63-S66.

PMID: 37853868 PMC: 10608360. DOI: 10.5021/ad.21.077.


Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.

Athni T, Barmettler S Ann Allergy Asthma Immunol. 2023; 130(6):699-712.

PMID: 36706910 PMC: 10247428. DOI: 10.1016/j.anai.2023.01.018.


Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Davis J, Ferreira D, Paige E, Gedye C, Boyle M Clin Microbiol Rev. 2020; 33(3).

PMID: 32522746 PMC: 7289788. DOI: 10.1128/CMR.00035-19.


Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease.

Parikh A, Vinnard C, Fahrenfeld N, Davidow A, Patrawalla A, Lardizabal A Int J Environ Res Public Health. 2019; 16(21).

PMID: 31683836 PMC: 6862550. DOI: 10.3390/ijerph16214250.


Biologic therapy in the idiopathic inflammatory myopathies.

Khoo T, Limaye V Rheumatol Int. 2019; 40(2):191-205.

PMID: 31680207 DOI: 10.1007/s00296-019-04467-6.